share_log

迈博药业-B(02181.HK)将于8月25日举行董事会会议以审批中期业绩

Maibo Pharmaceutical-B (02181.HK) will hold a board meeting on August 25 to approve interim results

Gelonghui Finance ·  Aug 14, 2023 04:42

02181.HK announced that a board meeting will be held on August 25, 2023 to consider and approve the interim results of the Company and its subsidiaries for the six months ended June 30, 2023.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment